We’re excited to share that our CEO, Chris Montalbano, has been featured in the August issue of Medical Design & Outsourcing (MDO). In his article, Chris explores five key technologies—manufacturing automation, machine learning, instrumentation standardization, consolidation/miniaturization, and connectivity—that are vital to advancing CAR T-cell therapy and making it more accessible to cancer patients.
Curious about how these technologies are shaping the future of CAR T-cell therapy and the regulatory challenges that come with them? You can read the full article here.
We do not share your information with third parties
